Anti-interleukin-6 therapy through application of a monogenic protein inhibitor via gene delivery

Anti-cytokine therapies have substantially improved the treatment of inflammatory and autoimmune diseases. Cytokine-targeting drugs are usually biologics such as antibodies or other engineered proteins. Production of biologics, however, is complex and intricate and therefore expensive which might li...

Descripción completa

Detalles Bibliográficos
Autores principales: Görtz, Dieter, Braun, Gerald S., Maruta, Yuichi, Djudjaj, Sonja, van Roeyen, Claudia R., Martin, Ina V., Küster, Andrea, Schmitz-Van de Leur, Hildegard, Scheller, Jürgen, Ostendorf, Tammo, Floege, Jürgen, Müller-Newen, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589789/
https://www.ncbi.nlm.nih.gov/pubmed/26423228
http://dx.doi.org/10.1038/srep14685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589789/
https://www.ncbi.nlm.nih.gov/pubmed/26423228
http://dx.doi.org/10.1038/srep14685

Ejemplares similares